ARCHIVES

Under A Flat Budget, NIH Suspends Grant Increases, May restore Funds Later.

This article is from The Cancer Letter archive.

Vol. 26 No. 43 | November 24, 2000

Download PDF Visit The Full Archive

Related Articles

Caterpillar In. Benefits Plan To Cover Entry On BMT trials

June 14, 1996

Study Tests PARP Inhibitor ABT-888 For Several Cancers

September 25, 2009

“Imaginary Treatments,” “Wonderful Cures”

June 6, 1997

ASCO Guidelines On CSFs Call For Use In Fewer Patients

December 2, 1994

FDA News: Zydelig approved in three B-cell blood cancers

August 1, 2014

Broder Appointment Official; Will Keep Retroviral Laboratory, Will Not Serve as NCI Clinical Director

January 6, 1989